Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-06-11FDA Approved: OLANZAPINE INTRAMUSCULAR — Original Application (UBI Pharma Inc.)
The FDA approved the intramuscular olanzapine generic from UBI Pharma Inc. under an Original Application, for use in agitation associated wi…
-
FDA approval · 2025-05-27FDA Approved: ASENAPINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for asenapine submitted by Alembic Pharmaceuticals Limited.
-
FDA approval · 2025-05-16FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone under an ANDA.
-
FDA approval · 2025-05-16FDA Approved: OLANZAPINE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original generic application for olanzapine, establishing a generic version of the antipsychot…
-
FDA approval · 2025-05-13FDA Approved: HALOPERIDOL DECANOATE — Original Application (Caplin Steriles Limited)
The FDA approved HALOPERIDOL DECANOATE as an original application for a generic long-acting injectable, used to treat schizophrenia. The sub…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-05-12EMA Authorised: Olanzapine Teva (olanzapine) — Teva B.V.
The EMA authorised Teva B.V. to market Olanzapine for schizophrenia and bipolar disorder in the European Union.
-
FDA approval · 2025-05-09FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Clozapine submitted by Aurobindo Pharma Limited, enabling the marketing of a generic Clozapine p…
-
FDA approval · 2025-04-24FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for haloperidol decanoate by Sagent Pharmaceuticals, updating regulatory approval for this long-acti…
-
FDA approval · 2025-04-15FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for lurasidone hydrochloride, enabling the generic to be marketed in the United…
-
FDA approval · 2025-03-27FDA Approved: PALIPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for paliperidone by Ajanta Pharma USA Inc., supporting a generic version of the drug. This action re…
-
FDA approval · 2025-03-18FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves BluePoint Laboratories' supplemental application for ZIPRASIDONE HYDROCHLORIDE, a generic form of ziprasidone, indicating appro…
-
FDA approval · 2025-03-12FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Abilify Maintena (aripiprazole) by Otsuka America Pharmaceutical, Inc. The product is a long…
-
FDA approval · 2025-02-28FDA Approved: LYBALVI — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for LYBALVI (olanzapine and samidorphan) expanding its labeling to include use for schizophrenia and…
-
FDA approval · 2025-02-26FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for Fluphenazine Decanoate from Novadoz Pharmaceuticals LLC.
-
FDA approval · 2025-02-26FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for Fluphenazine hydrochloride submitted by Novadoz Pharmaceuticals LLC. The approval pertains to a …
-
EMA approval · 2025-02-26EMA Authorised: Aripiprazole Accord (aripiprazole) — Accord Healthcare S.L.U.
The EMA authorised Aripiprazole Accord as a generic aripiprazole product for schizophrenia and bipolar disorder.
-
FDA approval · 2025-02-19FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Fluphenazine Decanoate by Hikma Pharmaceuticals USA Inc. for continued marketing of this long-ac…
-
FDA approval · 2025-02-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application from Bionpharma Inc. for aripiprazole (generic), enabling its continued commercialization with the a…
-
FDA approval · 2025-02-14FDA Approved: ARIPIPRAZOLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for aripiprazole from Bionpharma Inc., enabling the generic product to be marketed in the United Sta…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental application for aripiprazole (ARIPIPRAZOLE) under the ANDA pathway.
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for aripiprazole from Alembic Pharmaceuticals, enabling the marketing of a generic version. This…
-
FDA approval · 2025-01-24FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved a supplemental application for Fluphenazine hydrochloride by Zydus Pharmaceuticals (USA) Inc., indicating approval of changes t…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved Advagen Pharma Ltd's supplemental application for aripiprazole, authorizing a generic ARIPIPRAZOLE product with the same in…
-
FDA approval · 2025-01-24FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application from Apotex Corp. for aripiprazole (ANDA204094), authorizing changes to the generic product's approv…